# EDGAR Filing Document

**Accession Number:** 0001266806
**File Stem:** 0001753926-26-000974
**Filing Date:** 2026-6
**Character Count:** 7141
**Document Hash:** 2b328a1d245edcf077823979f0bbf27e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001753926-26-000974.hdr.sgml**: 20260604

**ACCESSION NUMBER**: 0001753926-26-000974

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 42

**CONFORMED PERIOD OF REPORT**: 20260604

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260604

**DATE AS OF CHANGE**: 20260604

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Vivani Medical, Inc.
- **CENTRAL INDEX KEY:** 0001266806
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 020692322
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36747
- **FILM NUMBER:** 261063212

**BUSINESS ADDRESS:**
- **STREET 1:** 1350 S. LOOP ROAD
- **CITY:** ALAMEDA
- **STATE:** CA
- **ZIP:** 94502
- **BUSINESS PHONE:** 415-506-8462

**MAIL ADDRESS:**
- **STREET 1:** 1350 S. LOOP ROAD
- **CITY:** ALAMEDA
- **STATE:** CA
- **ZIP:** 94502

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SECOND SIGHT MEDICAL PRODUCTS INC
- **DATE OF NAME CHANGE:** 20031010

?xml version='1.0' encoding='ASCII'? vani-20260604.htm

**UNITED STATES**<br>**SECURITIES AND EXCHANGE COMMISSION**<br>**Washington, D.C. 20549**<br>

**FORM** 8-K<br>

**CURRENT REPORT**

**Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):** June 4, 2026

**Vivani Medical, Inc.**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware**<br>| **001-36747**<br>| **02-0692322**<br>|
| **(State or other jurisdiction**<br>**of incorporation)** | **(Commission**<br>**File Number)** | **(IRS Employer**<br>**Identification No.)** |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;**1350 S. Loop Road**<br>Alameda**,** California | &nbsp;&nbsp;<br>**94502**<br>|
| &nbsp;&nbsp;**(Address of principal executive offices)** | &nbsp;&nbsp;**(Zip Code)** |

---

**Registrant's telephone number, including area code: (**415**)** 506-8462

**N/A**

**(Former name or former address, if changed since last report.)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $0.0001 per share<br>| VANI<br>| The Nasdaq Capital Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 7.01**. **Regulation FD Disclosure.** 

Vivani Medical, Inc., or Vivani, will make a presentation at the Jefferies Global Healthcare Conference in New York on Thursday, June 4, 2026 at 11:05 a.m. Eastern. A copy of a slide presentation that Dr. Adam Mendelsohn, Vivani's Chief Executive Officer intends to use during the conference is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated by reference herein. Vivani is also posting to the "Investors" portion of its website a copy of the slide presentation. The slide presentation speaks only as of the date of this Current Report on Form 8-K. While Vivani may elect to update the slide presentation in the future or reflect events and circumstances occurring or existing after the date of this Current Report on Form 8-K, Vivani specifically disclaims any obligation to do so.

The information contained in this Item 7.01 and Exhibit 99.1 hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by reference in such a filing.

**Item 9.01. Financial Statements and Exhibits.** 

(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| [<u>99.1</u>](ex991_1.htm) | [<u>Vivani Medical, Inc. slide presentation dated June</u> <u>4, 2026.</u>](ex991_1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  |  | **VIVANI MEDICAL, INC.** |
| Date: June 4, 2026 | By: | /s/ Donald Dwyer  |
|  | Name: | Donald Dwyer  |
|  | Title: | Chief Business Officer |

---

------

## Exhibit 99.1

<br>![Graphics](cf73efc0399b5e0d7f0f.jpg)<br>

------

<br>![Graphics](c2b77b5c295063630b8b.jpg)<br>

------

<br>![Graphics](c42291d55b4c38a8ebb3.jpg)

------

<br>![Graphics](c7613ef69c5940e92a6d.jpg)<br>

------

<br>![Graphics](ccccbc3cfc3e545f5089.jpg)

------

<br>![Graphics](c9c3065da6679d4aed86.jpg)<br>

------

<br>![Graphics](c57670cc8642d002ae54.jpg)<br>

------

<br>![Graphics](cbcf6239a4596331ff96.jpg)<br>

------

<br>![Graphics](c5374e281c87fbe71d11.jpg)

------

<br>![Graphics](c698a6d6f01333731013.jpg)<br>

------

<br>![Graphics](c3e8161ceabe22af10a4.jpg)

------

<br>![Graphics](c8c641bbdc22ff82847b.jpg)

------

<br>![Graphics](cca3c6fe9624dbeabfa2.jpg)

------

<br>![Graphics](c939cb319825e045a482.jpg)

------

<br>![Graphics](ce6de9e9f32f9656bf55.jpg)

------

<br>![Graphics](ce62c08de42bbe16dddc.jpg)

------

<br>![Graphics](cbb782f2635c4de76e25.jpg)

------

<br>![Graphics](cd944a8a963a16061226.jpg)

------

<br>![Graphics](c2b419f398b7ea42f3d2.jpg)

------

<br>![Graphics](c966f6f6922d6da58504.jpg)

------

<br>![Graphics](cf1ac5cfc7774304f809.jpg)

------

<br>![Graphics](c3869965ecb45d87c595.jpg)

------

<br>![Graphics](c22c38b9dc1d24d0bf92.jpg)<br>

------

<br>![Graphics](cccbb35b42abc4ca2546.jpg)

------

<br>![Graphics](c0163e5d8069cb0f6034.jpg)

------

<br>![Graphics](caf5718db2f14ae79f4c.jpg)

------

<br>![Graphics](c01cb41f8081ac6ef232.jpg)

------

<br>![Graphics](c60f935fc2a88f50a308.jpg)

------